Mendus AB (OSTO:IMMU) Long-Term Debt : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Long-Term Debt?

Mendus AB's Long-Term Debt for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Mendus AB's annual Long-Term Debt declined from Dec. 2022 (kr22.85 Mil) to Dec. 2023 (kr0.85 Mil) and declined from Dec. 2023 (kr0.85 Mil) to Dec. 2024 (kr0.00 Mil).

Mendus AB Long-Term Debt Historical Data

The historical data trend for Mendus AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Long-Term Debt Chart

Mendus AB Annual Data

Trend

Jun15

Jun16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

18.98

36.67

22.85

0.85

Mendus AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															0.85	-	-	-	-

Mendus AB (OSTO:IMMU) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Mendus AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Mendus AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Mendus AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

1YG0:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, 11153

Website

https://www.mendus.com

Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.